Farmak starts marketing Milt Nasal Drops

Farmak, the leader of the domestic pharmaceutical market, has added Milt to its line of nasal products. The dosage form of the medicine is 10 ml nasal drops.

Milt nasal drops is used:

• in symptomatic treatment of cold, nasal congestion, acute and chronic rhinitis, seasonal (hay fever) and non-seasonal allergic rhinitis, acute and chronic sinusitis, vasomotor rhinitis;
• in adjunctive therapy for acute otitis media;
• in preparation for nasal surgery and to eliminate swelling of the mucous membrane of the nose and paranasal sinuses after surgery.

Tetyana Dziuba, Marketing Consultant, Farmak, says, “Milt nasal drops is a combination medicine containing phenylephrine and dimethindene, with vasoconstrictive and anti-allergic effects. Double action of Milt nasal drops and its attractive safety profile have become the main criteria for adding the medicine to Farmak's product portfolio. Milt reduces nasal discharge and helps cleansing of the nasal passages without disturbing the physiological functions of ciliated epithelium and mucous membrane of the nose”.  

More news

A Company Where You’d Want to Work: Farmak Is Among Ukr...

Farmak has been named one of Ukraine’s top 50 employers for 2026, according to the business publication NV and Odgers Ukraine. As a leader in the Ukrainian pharmaceutical market, the company was recognized for its approach to supporting and developing its workforce. This year, employers were evaluated across four key areas: support for veterans and […...

Oct 21, 2026

Farmak International presented technologically complex ...

Farmak International participated in the international pharmaceutical exhibition CPHI Milan 2026, where, over the course of three days, it showcased its developments in the field of complex generics and injectable products. At CPHI Milan 2026, the Farmak International team held a series of meetings with existing and potential partners from various countries....

Oct 19, 2026

Farmak won the MMR 2026 PR case competition

Farmak’s entry, centered on the company’s 100th anniversary and the creation of the corporate film *Resilient Compound* (*Stiyka Spoluka*), won the “Best Internal PR” category at the MMR PR Case Competition 2026. The results were announced on September 25 during the Total PR Marathon 2026—a professional event bringing together members of the Ukra...

Oct 06, 2026